In summary, since the recognition of the RET proto-oncogene as the susceptibility gene for hereditary MTC several decades ago, advances have taken place in understanding pathogenesis of MTC and associated neoplasias. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.